Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

2
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (2)

Searched Name

Jerzy Krupinsky

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Muiño E, Cárcel-Márquez J, Carrera C, Llucià-Carol L, Gallego-Fabrega C, Cullell N, Lledós M, Castillo J, Sobrino T, Campos F, Rodríguez-Castro E, Millán M, Muñoz-Narbona L, Bustamante A, López-Cancio E, Ribó M, Álvarez-Sabín J, Jiménez-Conde J, Roquer J, Giralt-Steinhauer E, Soriano-Tárraga C, Vives-Bauza C, Navarro RD, Tur S, Obach V, Arenillas JF, Segura T, Serrano-Heras G, Martí-Fàbregas J, Delgado-Mederos R, Camps-Renom P, Prats-Sánchez L, Guisado D, Guasch M, Marin R, Martínez-Domeño A, Freijo-Guerrero MDM, Moniche F, Cabezas JA, Castellanos M, Krupinsky J, Strbian D, Tatlisumak T, Thijs V, Lemmens R, Slowik A, Pera J, Heitsch L, Ibañez L, Cruchaga C, Dhar R, Lee JM, Montaner J, Fernández-Cadenas I. RP11-362K2.2:RP11-767I20.1 Genetic Variation Is Associated with Post-Reperfusion Therapy Parenchymal Hematoma. A GWAS Meta-Analysis. J Clin Med 2021;10:jcm10143137. [PMID: 34300314 PMCID: PMC8305811 DOI: 10.3390/jcm10143137] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Revised: 07/05/2021] [Accepted: 07/14/2021] [Indexed: 12/12/2022] Open

Affiliation(s)

Elena Muiño Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (E.M.); (J.C.-M.); (L.L.-C.); (C.G.-F.); (N.C.); (M.L.)
Jara Cárcel-Márquez Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (E.M.); (J.C.-M.); (L.L.-C.); (C.G.-F.); (N.C.); (M.L.)
Caty Carrera Neurovascular Research Laboratory, Vall d’Hebron Institut de Recerca, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain;
Laia Llucià-Carol Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (E.M.); (J.C.-M.); (L.L.-C.); (C.G.-F.); (N.C.); (M.L.)
Cristina Gallego-Fabrega Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (E.M.); (J.C.-M.); (L.L.-C.); (C.G.-F.); (N.C.); (M.L.) Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Natalia Cullell Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (E.M.); (J.C.-M.); (L.L.-C.); (C.G.-F.); (N.C.); (M.L.) Stroke Pharmacogenomics and Genetics, Fundació MútuaTerrassa per la Docència i la Recerca, 08221 Terrassa, Spain
Miquel Lledós Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (E.M.); (J.C.-M.); (L.L.-C.); (C.G.-F.); (N.C.); (M.L.)
José Castillo Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; (J.C.); (T.S.); (F.C.)
Tomás Sobrino Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; (J.C.); (T.S.); (F.C.)
Francisco Campos Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; (J.C.); (T.S.); (F.C.)
Emilio Rodríguez-Castro Department of Neurology, Hospital Clínico Universitario de Santiago, 15706 Santiago de Compostela, Spain;
Mònica Millán Department of Neuroscience, Hospital Germans Trias i Pujol, 08025 Badalona, Spain; (M.M.); (L.M.-N.); (A.B.)
Lucía Muñoz-Narbona Department of Neuroscience, Hospital Germans Trias i Pujol, 08025 Badalona, Spain; (M.M.); (L.M.-N.); (A.B.)
Alejandro Bustamante Department of Neuroscience, Hospital Germans Trias i Pujol, 08025 Badalona, Spain; (M.M.); (L.M.-N.); (A.B.)
Elena López-Cancio Stroke Unit, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain;
Marc Ribó Stroke Unit, Hospital Universitario Valle de Hebrón, 08025 Barcelona, Spain;
José Álvarez-Sabín Department of Neurology, Hospital Universitario Valle de Hebrón, Universidad Autónoma de Barcelona, 08025 Barcelona, Spain;
Jordi Jiménez-Conde Department of Neurology, Neurovascular Research Group, Instituto de Investigaciones Médicas Hospital del Mar-Hospital del Mar, 08025 Barcelona, Spain; (J.J.-C.); (J.R.); (E.G.-S.); (C.S.-T.)
Jaume Roquer Department of Neurology, Neurovascular Research Group, Instituto de Investigaciones Médicas Hospital del Mar-Hospital del Mar, 08025 Barcelona, Spain; (J.J.-C.); (J.R.); (E.G.-S.); (C.S.-T.)
Eva Giralt-Steinhauer Department of Neurology, Neurovascular Research Group, Instituto de Investigaciones Médicas Hospital del Mar-Hospital del Mar, 08025 Barcelona, Spain; (J.J.-C.); (J.R.); (E.G.-S.); (C.S.-T.)
Carolina Soriano-Tárraga Department of Neurology, Neurovascular Research Group, Instituto de Investigaciones Médicas Hospital del Mar-Hospital del Mar, 08025 Barcelona, Spain; (J.J.-C.); (J.R.); (E.G.-S.); (C.S.-T.)
Cristófol Vives-Bauza Neurobiology Laboratory, Instituto de Investigación Sanitaria de Palma, 07120 Mallorca, Spain;
Rosa Díaz Navarro Department of Neurology, Hospital Universitari Son Espases, 07120 Mallorca, Spain; (R.D.N.); (S.T.)
Silvia Tur Department of Neurology, Hospital Universitari Son Espases, 07120 Mallorca, Spain; (R.D.N.); (S.T.)
Victor Obach Department of Neurology, Hospital Clínic i Provincial de Barcelona, 08025 Barcelona, Spain;
Juan F. Arenillas Department of Neurology, Hospital Clínico Universitario, University of Valladolid, 47003 Valladolid, Spain;
Tomás Segura Department of Neurology, Complejo Hospitalario Universitario de Albacete, 02006 Albacete, Spain;
Gemma Serrano-Heras Experimental Research Unit, Complejo Hospitalario Universitario de Albacete, 02006 Albacete, Spain;
Joan Martí-Fàbregas Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Raquel Delgado-Mederos Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Pol Camps-Renom Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Luis Prats-Sánchez Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Daniel Guisado Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Marina Guasch Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Rebeca Marin Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Alejandro Martínez-Domeño Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain; (J.M.-F.); (R.D.-M.); (P.C.-R.); (L.P.-S.); (D.G.); (M.G.); (R.M.); (A.M.-D.)
Maria del Mar Freijo-Guerrero Neurovascular Unit, Biocruces Bizkaia Health Research Institute, 48903 Bilbao, Spain;
Francisco Moniche Department of Neurology, Virgen del Rocío, Instituto de Biomedicina de Sevilla, 41013 Seville, Spain; (F.M.); (J.A.C.); (J.M.)
Juan Antonio Cabezas Department of Neurology, Virgen del Rocío, Instituto de Biomedicina de Sevilla, 41013 Seville, Spain; (F.M.); (J.A.C.); (J.M.)
Mar Castellanos Department of Neurology, Complejo Hospitalario Universitario A Coruña, 15006 A Coruña, Spain;
Jerzy Krupinsky School of Healthcare Science, Manchester Metropolitan University, Manchester M15 6BH, UK; Neurology Unit, Hospital Universitari Mútua Terrassa, 08221 Terrassa, Spain
Daniel Strbian Department of Neurology, Helsinki University Hospital, FI-00029 Helsinki, Finland;
Turgut Tatlisumak Department of Clinical Neuroscience, Institute of Neurosciences and Physiology, Sahlgrenska Academy at University of Gothenburg, 41345 Gothenburg, Sweden; Department of Neurology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden
Vincent Thijs Stroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg VIC 3072, Australia; Department of Neurology, Austin Health, Heidelberg VIC 3072, Australia
Robin Lemmens Department of Neurology, University Hospitals Leuven, Campus Gasthuisberg, 3000 Leuven, Belgium;
Agnieszka Slowik Department of Neurology, Jagiellonian University Medical College, 31-007 Kraków, Poland; (A.S.); (J.P.)
Joanna Pera Department of Neurology, Jagiellonian University Medical College, 31-007 Kraków, Poland; (A.S.); (J.P.)
Laura Heitsch Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO 63110-1010, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110-1010, USA; (R.D.); (J.-M.L.)
Laura Ibañez Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110-1010, USA; (L.I.); (C.C.)
Carlos Cruchaga Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110-1010, USA; (L.I.); (C.C.)
Rajat Dhar Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110-1010, USA; (R.D.); (J.-M.L.)
Jin-Moo Lee Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110-1010, USA; (R.D.); (J.-M.L.)
Joan Montaner Department of Neurology, Virgen del Rocío, Instituto de Biomedicina de Sevilla, 41013 Seville, Spain; (F.M.); (J.A.C.); (J.M.)
Israel Fernández-Cadenas Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; (E.M.); (J.C.-M.); (L.L.-C.); (C.G.-F.); (N.C.); (M.L.) Correspondence:
on behalf of International Stroke Genetic Consortium
the Spanish Stroke Genetic Consortium

Collapse

Gulya TJ, Krupinsky J, Draper M, Charlet LD. First Report of Charcoal Rot (Macrophomina phaseolina) on Sunflower in North and South Dakota. Plant Dis 2002;86:923. [PMID: 30818662 DOI: 10.1094/pdis.2002.86.8.923a] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]

Abstract

In September 1998, symptoms suggestive of charcoal rot were observed on oilseed sunflower (Helianthus annuus L.) plants in western North and South Dakota. Symptoms first observed on plants approaching physiological maturity consisted of silver-gray lesions girdling the stem at the soil line, premature plant death, and reduced head diameter. The pith in the lower stem was completely absent or compressed into horizontal layers. Black, spherical microsclerotia were observed in the pith of the lower stem, underneath the epidermis, and on the exterior of the taproot. Confirmation of Macrophomina phaseolina (Tossi) Goid. as the causal agent was based on the size of the microsclerotia, which ranged from 80 to 90 μm in diameter, from both infected sunflowers and pure cultures (1). The only other sunflower pathogen known to form microsclerotia is Verticillium dahliae Kleb., whose microsclerotia are irregular in shape and are 15 to 50 μm in diameter. Some prematurely dead sunflower plants lacked typical charcoal rot stem lesions, but contained Macrophomina microsclerotia. Plants with atypical symptoms were colonized by the sunflower stem weevil (Cylindrocopturus adspersus (LeConte)) and the black sunflower stem weevil (Apion occidentale Fall). This agrees with observations in Texas, where Macrophomina-infected sunflower plants parasitized by stem-feeding insects often displayed atypical charcoal rot symptoms (3). Charcoal rot incidence in 1998 in western North Dakota was 25%, compared with 0% in eastern North Dakota. Charcoal rot was not observed in 1999, the fourth wettest growing season on record, but was observed again in 2000 and 2001. The recent increase in sunflower production in western North and South Dakota, areas typically hotter and drier than the eastern portions of both states, and the potential involvement of stem weevils as vectors of Macrophomina (2) may lead to an increased incidence of charcoal rot in sunflower. References: (1) P. Holliday and E. Punithalingam. Macrophomina phaseolina. No. 275 in: Description of Pathogenic Fungi and Bacteria, CMI, Kew, Surrey, UK, 1970. (2) S. M. Yang et al. Phytopathology 73:1467, 1983. (3) S. M. Yang and D. F. Owen. Phytopathology 72:819, 1982.

Collapse